Annals On Call Podcast cover image

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes

Annals On Call Podcast

00:00

Understanding Study Outcomes in Type 2 Diabetes Research

This chapter outlines the inclusion criteria for patients in a type 2 diabetes study, focusing on age and medical history. It also details the primary and secondary outcomes of the trial, including mortality and cardiovascular events over a 2.2-year follow-up period.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app